Podcasts about guidelines

In this episode, Dr. David Jockers dives into the benefits of the Protein Sparing Modified Fast, a powerful tool for burning fat, especially visceral fat. He explains how this strategy promotes fat loss while preserving lean muscle mass, even with a calorie-restricted diet.   Dr. Jockers shares how fasting triggers autophagy and the role it plays in cellular rejuvenation, helping the body break down old, damaged mitochondria and replace them with healthier ones.   He also discusses how protein-sparing fasting impacts insulin sensitivity, brain function, and overall resilience, while offering practical tips for implementing this approach into your lifestyle.   In This Episode:  00:00 Introduction to Fasting and Its Historical Context 00:48 Protein Sparing Modified Fast Explained 06:57 Dr. Jockers' Journey into Holistic Health 12:45 Introduction to Fasting Practices 14:20 Personal Fasting Experience and Benefits 17:32 Intermittent Fasting and Its Popularization 27:20 Autophagy and Cellular Rejuvenation 36:21 Challenges of Extended Fasting 37:13 Introduction to Protein Sparing Modified Fast 37:54 Benefits and Guidelines of Protein Sparing Modified Fast 40:35 Practical Tips for Protein Sparing Modified Fast 45:15 Addressing Common Concerns About Fasting 48:53 The Role of Ketones in Brain Health 54:42 Spiritual and Physical Benefits of Fasting 56:42 Autophagy and Protein Sparing Modified Fast 01:03:33 Tips for Enhancing Insulin Sensitivity 01:06:20 Favorite Meals and Desserts 01:08:31 Concluding Thoughts and Favorite Bible Verse   If you want practical, natural strategies to balance your hormones, heal your gut, boost your energy, and slow aging, don't miss The Dr. Josh Axe Show. Dr. Axe blends ancient wisdom with cutting-edge science and brings on world-class experts for unfiltered conversations you won't hear anywhere else. Transform your health from the inside out and subscribe to The Dr. Josh Axe Show, with new episodes every Monday and Thursday.   If you're looking to boost your health naturally, Paleo Valley's Super Greens powder is a game-changer. Packed with 23 organic superfoods, it provides all the nutrients your body needs for boundless energy and vitality, without the digestive issues that come with cereal grasses. For 15% off, visit paleovalley.com/jockers and use code JOCKERS at checkout.   When it comes to cooking, Chef Foundry offers the perfect solution with their P 600 ceramic cookware, which is free from Teflon, PFAS, and plastic coatings. Made with Swiss-engineered ceramic, this cookware makes it easy to prepare healthy meals without the toxins. Take 20% off with code SAFE20 at chefsfoundry.com/jockers and upgrade your kitchen today.     "Protein Sparing Modified Fast helps quench satiety, and most people on it don't feel as hungry or have cravings."      Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio   Resources: Visit paleovalley.com/jockers for 15% off with code JOCKERS. Visit chefsfoundry.com/jockers for 20% off with code SAFE20. Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: (Stacey Track) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. We are less than one month from our first MNO of 2026. Please join us in Silver Spring MD Feb 20 and 21. It's going to be amazing. We're going to Nashville next March 6-7 and we're going to have a great event a Club 1921 we just added on Thursday March 5th for health care providers and patient leaders. All the info is over at diabetes-connetionss.com events/ Okay.. our top story this week: XX   All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. This is the ELSA study - Early Surveillance for Autoimmune diabetes, a first of its kind UK study. They tested blood samples from 17,931 children aged 3-13 for autoantibodies, markers of type 1 diabetes that can appear years before symptoms. Families of children found to have early-stage type 1 diabetes received tailored education and ongoing support to prepare for the eventual onset of type 1 diabetes symptoms and to ensure insulin therapy can begin promptly when needed, reducing the chances of needing emergency treatment. Those with one autoantibody also received ongoing support and monitoring.   Some families were also offered teplizumab, the first ever immunotherapy for type 1 diabetes, which can delay the need for insulin by around three years in people with early-stage type 1 diabetes. The second phase has launched and will expand screening to all children in the UK aged 2-17 years, with a focus on younger children (2-3 years) and older teenagers (14-17 years). The research team aims to recruit 30,000 additional children across these new age groups. ELSA 2 will assess how screening can be scaled across the NHS and evaluate its cost-effectiveness. https://www.birmingham.ac.uk/news/2026/childhood-type-1-diabetes-screening-is-effective-and-could-prevent-thousands-of-emergency-diagnoses XX At the J.P. Morgan Healthcare Conference Dexcom CEO Jake Leach says they're going to launch a new product outside the US. I'll link up that interview, The full quote: "When you look at the outside the U.S., there are a lot of structures that are tiered. Patients have access to different types of products, so we've got a new one that we want to introduce that will add flexibility there. It's based on the G7 platform, just like Dexcom ONE+, but it has a unique experience that's tailored for a subset of users that, today, don't have access to Dexcom." Your guess is as good as mine, but sounds more like a pricing or ordering issue than a new bit of hardware or software. Dexcom will also bring Stelo to some international markets this year. And plans a new mobile app experience for the wearable biosensor meant for people who don't dose insulin. Leach also says G8 will be much smaller and with more capability. but is a few years away. https://www.drugdeliverybusiness.com/dexcom-ceo-jake-leach-2026-roadmap-jpm/ XX A new international consensus statement provides guidance for the use of diabetes technology during pregnancy for women with type 1 diabetes (T1D), type 2 diabetes (T2D), or gestational diabetes (GD).   Organized by the diaTribe Foundation, the document was based on evidence where available, as well as opinion from an international group of experts in endocrinology, diabetes technology, and obstetrics & gynecology, among others.   This is the first set of recommendations specifically addressing the use of diabetes technology in pregnancy – and we'll link it up. https://www.medscape.com/viewarticle/new-consensus-statement-addresses-diabetes-tech-pregnancy-2026a100020d XX Bariatric surgery beats GLP-1s for type 2 diabetes across income levels. This study was published this month, looking at nearly 300 patients are 4 medical centers. Success here is measured by lower blood glucose levels, higher weight loss (28% vs. 10%), less use of diabetes medications, remission of diabetes to the point of no longer needing to inject insulin, and reduced risk factors for cardiovascular disease.     Bariatric surgery was better than medical therapy across all social backgrounds, they found, and not just in areas of higher deprivation. The ancillary study was smaller, and some of the participants randomized in earlier stages crossed over from medical to surgical treatment, and the reverse. The authors acknowledged and accounted for these limitations, along with the rapid development of more powerful obesity drugs not fully captured in the study. This was a long term study – more than 12 years – and by the end of the study more people were choosing GLP1 medications. One dividing line: If someone hopes to lose 100 pounds, that's more likely with surgery than with medications.  "Ultimately, we need large, long-term, well-designed studies to clarify the best strategy for a given patient." https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ XX Researchers at the University of California, Riverside have reported for the first time that a father's exposure to microplastics (MPs) can lead to metabolic problems in his children, including diabetes. This is a mouse study, but it looks at a previously unrecognized way in which environmental pollution may influence the health of future generations. MPs are extremely small plastic fragments, measuring less than 5 millimeters, that form as consumer products and industrial materials break down. Metabolic disorders describe a group of conditions that include elevated blood pressure, high blood sugar, and excess body fat, all of which raise the risk of heart disease and diabetes. The team found that female offspring of male mice exposed to MPs were far more prone to metabolic disorders than offspring of unexposed fathers, even though all offspring received the same high fat diet.     The research team hopes the findings will guide future investigation into how MPs and even smaller nanoplastics affect human development.   https://scitechdaily.com/microplastics-can-rewire-sperm-triggering-diabetes-in-the-next-generation/ XX The FDA has finalized four new recalls for certain lots of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to ongoing safety concerns. We told you about this in November when Abbott says some of its continuous glucose monitoring (CGM) sensors were providing incorrect low glucose warnings. Internal testing identified the issue—carbon building up in the sensors during the manufacturing process—and determined that approximately 3 million CGM sensors were affected. The sensors were distributed in the United States, Canada and several European countries.  When Abbott shared that announcement, the FDA was still reviewing the situation. No recalls had yet been finalized. Now, however, the agency has announced four new Class I recalls.   https://cardiovascularbusiness.com/topics/clinical/heart-health/fda-confirms-recalls-abbott-cgm-sensors-new-lawsuit-alleges-company-concealed-information XX   Insulet brings back it's U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products. Insulet began recycling pilot programs in Mass and California and are rolling it out nationwide. Insulet also has "Pod takeback" programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.   https://www.drugdeliverybusiness.com/insulet-expands-us-pod-recycling-program/ XX Up next a new resource for a population at three times the risk for diabetes, but without a lot of access to health information. I The first diabetes information website primarily in ASL has launched. The site includes GIFs and videos on diabetes management and an ASL glossary of diabetes-related terms. This is from University of Utah Health – Called Deaf Diabetes Can Together. Deaf and hard of hearing people are at three times higher risk for diabetes, but access to health information in ASL is limited. https://healthcare.utah.edu/newsroom/news/2026/01/first-diabetes-information-website-asl-launches XX Novo Nordisk ended all work on cell therapies, including a Type 1 diabetes program, in October – and now has found a buyer. Aspect has acquired rights to the assets and giving Novo an option to reengage for later-stage development and commercialization. Novo is helping bankroll Aspect's development of the assets, investing in the company and providing research funding. The arrangement gives Novo a chance to profit from the programs down the line. Novo is eligible for royalties and milestone payments on future product sales and, having handed the reins to Aspect for now, can expand its role in later-stage development and commercialization. The integration will involve the transfer of capabilities and expertise from Novo sites in Denmark and the U.S. to Aspect's Canadian operations. https://www.fiercebiotech.com/biotech/novo-nordisk-offloads-diabetes-assets-aspect-amid-cell-therapy-retreat XX XX Lucas Escobar has carved a role by proving that healthcare marketing can be culturally resonant, commercially powerful and deeply human. As director and head of U.S. consumer marketing at Insulet, he has redefined how the Omnipod tubeless insulin pump shows up in culture, transforming a medical device into a symbol of identity, inclusion and empowerment.   Under Escobar's leadership, Insulet launched three breakthrough initiatives: Dyasonic: Sound of Strength, a Marvel comic collaboration introducing a superhero who uses Omnipod; The Pod Drop, which turned the sound of a pod change into a celebratory music track; and Omnipod Mango x Pantone, medtech's first color partnership, honoring the vibrancy of the diabetes community. Each blended creativity with purpose while driving results, helping fuel Omnipod's consistent double-digit growth and its position as the most prescribed insulin pump in the U.S.   Living with type 1 diabetes himself, Escobar brings lived experience to his work, using storytelling not just to sell, but to make people feel seen.   Click here to return to the 2026 MM+M 40 Under 40 homepage.   From the January 01, 2026 Issue of MM+M - Medical Marketing and Media https://www.mmm-online.com/40-under-40/40-under-40-lucas-escobar-insulet/ -- FDA approves an update to the prescribing info for Afrezza inhaled insulin. This is a revision to the recommendations for the starting mealtime dosage when patients switch from shots or insulin pumps. This is aimed at healthcare providers - the updated labeling was supported by results from the INHALE-3 trial. The FDA is still considering approval of Afrezza for kids – a decision there expect by summer. https://www.globenewswire.com/news-release/2026/01/26/3225442/29517/en/MannKind-Announces-FDA-Approval-of-Updated-Afrezza-Label-Providing-Starting-Dose-Guidance-when-Switching-from-Multiple-Daily-Injections-MDI-or-Insulin-Pump-Mealtime-Therapy.html   -- UK researchers have developed a calculator to predict whether someone is at risk for type 1 diabetes. They're hoping this helps in screening and in preventing DKA at diagnosis. They used the TEDDY study to create this calculator, which right now is in beta form and only for kids and teens ages 8-18. The current beta form of the calculator asks users to answer questions about four factors necessary to estimate a child's risk of developing type 1 diabetes: age, family history, number of confirmed autoantibodies, and genetic risk score. The calculator has been given regulatory approval as a diagnostic in the U.K., and he's working with a company that's hoping to bring it to the U.S. in the next few months in the form of a home genetic test kit. https://www.healthcentral.com/news/type-1-diabetes/new-calculator-might-help-predict-type-1-diabetes-before-symptoms-appear

Today, we dive into one of the most critical topics in chiropractic care: the real-world effectiveness of strategies for implementing guideline-concordant care for low back pain. We'll explore recent research that asks a simple but powerful question—do strategies designed to promote best practices in low back pain management actually change provider behavior?Research: Effectiveness of strategies for implementing guideline-concordant care in low back pain: a systematic review and meta-analysis of randomised controlled trialsSpecial Offers for Listeners: Learn more about Diabetes Reversal Group and become a licenseeSave $500 and Get a Free Cart- Learn more at Shockwave Center of America Today!Leander Tables- Save $1,000 on the Series 950 Table using the code EBC2025 — their most advanced flexion-distraction tableNovoPulse OA Recovery Program- learn more herePatient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

January is tough, but February can be a surprisingly powerful reset if you know how to use it. In this episode, we share why this month often feels draining, how hidden energy leaks show up across your day, and how a simple February energy audit can help you make small, strategic shifts that protect your time and capacity. Our goal is to help you stop drifting through February and start using it to refill your tank before the rest of the year ramps up.Prefer to read? Grab the episode transcript and resources in the show notes here: https://www.secondstorywindow.net/podcast/february-teacher-energy-tips/Resources:February Teacher Survival KitJoin the Teacher Approved Club!BlueAir humidifierHinge toppersConnect with us on Instagram @2ndstorywindow.Shop our teacher-approved resources.Join our Facebook group, Teacher ApprovedLeave a review on Apple Podcasts.Leave a comment or rating on Spotify.Related Episodes to Enjoy:Episode 48. How to Make Classroom Transitions Simple with Clear Beginnings and EndingsEpisode 49. Rapid Classroom Transitions: How to Save 45 Hours a YearEpisode 50. 3 Guidelines to Make Classroom Transitions Work Smarter Not HarderEpisode 161, How to Get Students Actively Engaged: 5 Teacher Approved Techniques

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Benjamin Tolchin, MD, MS, FAAN, joins the podcast to provide clinical perspective on the recently published American Academy of Neurology (AAN) guidelines on functional seizures, drawing on his role as a contributing author to the recommendations. Tolchin, Director of the Center for Clinical Ethics at Yale New Haven Health and Associate Professor of Neurology at Yale School of Medicine, discusses what prompted the development of the first AAN guideline in this space and how the evidence base evolved to support formal recommendations. The conversation explores key considerations around diagnosing functional seizures, including history, semiology, EEG use, and the growing role of video documentation. Tolchin also addresses how clinicians should approach psychiatric comorbidities and co-occurring epilepsy, the evidence supporting psychological interventions, why pharmacologic therapies are not recommended for functional seizures themselves, and where major gaps remain in research to advance care in the years ahead.Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.Episode Breakdown: 1:10 – Why growing evidence prompted the first AAN guideline on functional seizures 3:20 – Diagnostic priorities including history, semiology, EEG, and video documentation 6:15 – Assessing psychiatric comorbidities and co-occurring epilepsy in functional seizures 9:15 – Neurology News Minute 11:30 – Evidence supporting psychotherapy for functional seizures 14:50 – Pharmacological evidence and use of antiseizure medications for functional seizures 18:35 – Barriers to advancing clinical trials in functional seizures 22:05 – Research priorities to refine treatment and long-term outcomes The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode, we review the clinical presentation, diagnosis, and treatment of uncomplicated urinary tract infections. Key Concepts Uncomplicated urinary tract infections (UTI) are defined as an infection localized to the bladder without any systemic signs or symptoms of infection in someone who is not immunocompromised, pregnant, catheterized, and has normal urologic anatomy. UTIs are most commonly seen in younger women. E. coli is by far the most common urinary pathogen. Symptoms alone drive most of the diagnosis of UTI; however, urinalysis and urine culture can be helpful in some circumstances. Nitrofurantoin (Macrobid) is recommended for men and women for first-line therapy in most patients. Fosfomycin, Bactrim, pivmecillinam, and certain B-lactams can be considered in certain circumstances. Women are usually treated for 3-5 days and men 5-7 days. Some evidence suggests inferior clinical outcomes for B-lactam; however, the amount of data in general is lacking for B-lactams. Recommended B-lactams (aside from pivmecillinam) include amoxicillin/clavulanate, cephalexin, cefadroxil, cefpodoxime, and cefdinir. References Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024;7(11):e2444495. Published 2024 Nov 4. doi:10.1001/jamanetworkopen.2024.44495 Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257 Kurotschka PK, Gágyor I, Ebell MH. Acute Uncomplicated UTIs in Adults: Rapid Evidence Review. Am Fam Physician. 2024;109(2):167-174. https://www.wikiguidelines.org/

When the U.S. government released the new 2025–2030 Dietary Guidelines for Americans, most people probably didn't notice what didn't make headlines. But something important changed. For the first time in decades, the federal government removed specific drinking limits from its alcohol guidance. Gone was the already-weak recommendation of no more than one drink per day for women. Also missing? Any clear warning about alcohol's well-established link to cancer. What replaced it was vague language encouraging people to “drink less.” That might sound harmless. Reasonable, even. But when you look closely at the science—and the political and economic forces surrounding alcohol—this shift isn't neutral. It's dangerous. And it represents a clear retreat from evidence-based public health guidance at a time when alcohol-related harm in the U.S. is rising. In this episode, I'm taking a position:The new U.S. alcohol guidelines caved to Big Alcohol—and the consequences matter. For the full show notes, kindly go to this podcast episode link: https://hellosomedaycoaching.com/the-new-u-s-alcohol-guidelines-caved-to-big-alcohol-and-why-thats-dangerous/ 4 Ways I Can Support You In Drinking Less + Living More Join The Sobriety Starter Kit, the only sober coaching course designed specifically for busy women. My proven, step-by-step sober coaching program will teach you exactly how to stop drinking  — and how to make it the best decision of your life. Save your seat in my FREE MASTERCLASS, 5 Secrets To Successfully Take a Break From Drinking  Grab the Free 30-Day Guide To Quitting Drinking, 30 Tips For Your First Month Alcohol-Free. Connect with me for free sober coaching tips, updates + videos on YouTube, Instagram, Facebook, Pinterest and TikTok @hellosomedaysober. Love The Podcast and Want To Say Thanks? ☕ Buy me a coffee! In the true spirit of Seattle, coffee is my love language. So if you want to support the hours that go into creating this show each week, click this link to buy me a coffee and I'll run to the nearest Starbucks + lift a Venti Almond Milk Latte and toast to you! https://www.buymeacoffee.com/hellosomeday 

Nicholas Pfaff, Deputy Chief Executive and Head of Sustainable Finance, ICMA introduces the Climate Transition Bond Guidelines and their role in mobilising capital for hard-to-abate sectors.

In this episode of Iron Culture, Eric Helms and Eric Trexler discuss the recent changes to the Dietary Guidelines for Americans (DGAs) and the implications of these updates. They begin by addressing the shift in their podcast schedule, emphasizing the importance of mental health and balance in their work. The conversation then transitions into a detailed analysis of the new dietary guidelines, highlighting the complexities of the process behind their formulation. Helms critiques the influence of corporate interests and the political landscape on the DGAs, while also acknowledging the positive aspects of the new recommendations, particularly the increased emphasis on protein intake. The hosts explore the historical context of dietary guidelines, the evolution of public health messaging, and the challenges of effectively communicating nutritional advice to the public. In this episode, Eric Helms and MASS Research delve into the complexities of the latest Dietary Guidelines for Americans (DGAs), discussing the implications of the visual representation of food groups and the recommendations for protein, fats, and processed foods. They critique the new guidelines for their lack of clarity and potential confusion, particularly regarding the emphasis on whole foods versus processed foods. The conversation highlights the disconnect between the written guidelines and their visual representation, which may mislead the public about healthy eating patterns. They also explore the political influences on these guidelines and how they may affect vulnerable populations, particularly in school lunch programs and social assistance programs. If you're in the market for some lifting gear or apparel, be sure to check out EliteFTS.com (and use our code "MRR10" for a 10% discount) Chapters 00:00 Introduction and Schedule Changes 07:15 The Dietary Guidelines Controversy 20:56 Understanding the Formation of Dietary Guidelines 32:30 The Influence of Food Industries on Guidelines 33:38 The Role of the Second Committee 43:49 Changes in Protein Recommendations 44:19 The Inverted Pyramid and Dietary Miscommunication 59:55 Understanding Fats in the New Guidelines 01:09:17 The Role of Full-Fat Dairy in Heart Health 01:15:06 Alcohol Consumption: New Guidelines Explained 01:21:52 Processed Foods and Public Health Implications 01:25:03 The Impact of Dietary Guidelines on Vulnerable Populations 01:30:34 Conclusions and Future Directions in Nutrition Guidelines

When you're preparing for NP boards, screening guidelines can seem a little dry, but these recommendations show up consistently on exams and form the foundation of primary care practice.   In this episode, Courtney and I run through an overview of the adult screening recommendations you'll need to know for primary care NP boards, leaning heavily on USPSTF recommendations.   Discover how to think through screening questions without getting lost in the nitty gritty detail.   Get full show notes, transcript, and more information here: https://blog.npreviews.com/primary-care-screening-guidelines-pass-np-boards   Follow us on Instagram: instagram.com/smnpreviewsofficial        

On this episode of Vitality Radio, Jared introduces a new series: The Vitality Verdict: Beyond the Headlines—designed to cut through the noise (and the politics) of natural health news and give you a clear, evidence-based perspective you can actually use. Using the newly released 2025–2030 Dietary Guidelines as the first case study, Jared breaks down what changed and why it matters for real life—especially for school lunches, WIC, and other programs that shape how millions of Americans eat. He also examines conflicts of interest on both sides of the debate and delivers his bottom-line Vitality Verdict on what this shift means for your health choices going forward.Products:Vitality Radio POW! Product of the Week: ZHOU Creatine Gummies BUY ONE GET ONE FREE! A $34.99 value! PROMO CODE: POW24Additional Information:RealMilk.comThe Westin A. Price FoundationVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

185

Are Podcast Chapters a good thing?Most people would say "Of course they are".Steve has reservations, mostly because chapters help listeners more easily skip ads, and that's not a good thing for clients who have ads in their show. However, Podcast Chapters are useful. And very cool...especially when you hear about what can be done with Chapter Images (see chapter #11 of this episode)!In our conversation with Daniel J. Lewis, we talk through all the ins and outs of podcast chapters, their benefits, and how they can transform your client's show into a more interactive experience for your audience.Key takeaways:Podcast chapters enhance navigation and engagementThey allow for additional multimedia elements, enriching the listener experienceProperly structured chapters can improve retention and manage ad placements effectivelyKey Moments (aka: Chapters):(00:00) Daniel J. Lewis Explains the Technical Side of Podcast Chapters(02:44) Are Chapters a Good Thing?(04:58) Making Ads More Actionable with Chapters(08:43) Making Ads More Engaging(10:16) Hiding Chapters in the Table of Contents(12:17) Media Hosts and Adding Chapters(16:08) Should Spotify and Apple Podcasts make our Chapters?(21:02) The Lazy Benefit of Automated Chapters(23:08) Formatting Chapters for Optimal Performance(28:02) What about Chapter Images?(34:09) GIFs as Chapter Images! Really!(34:53) Guidelines for Chapter Images(40:53) PodChapters.comResources:Daniel's Podcast Chapters tool: https://PodChapters.comEpisode about how to use Chapters on The Audacity to Podcast: https://theaudacitytopodcast.com/why-and-how-to-use-podcast-chaptersJSON chapters: https://podcasting2.org/docs/podcast-namespace/tags/chaptersDaniel's Subscribe and Follow plugin for WordPress: *https://SteveStewart.me/subscribeandfollowDaniel's Podgagement service for tracking podcast chart rankings and reviews *https://SteveStewart.me/podgagementAbout Daniel J. Lewis (2026)As Hall of Fame podcasting educator, advocate, and innovator, Daniel gives you the guts and teaches you the tools to start and grow your own podcasts for passion and P.R.O.F.I.T.Daniel has been podcasting since 2007 and has created numerous resources for podcasting, such as hosting award-winning The Audacity to Podcast, he created the Podgagement service to help podcasters supercharge their podcast engagement, and co-founded International Podcast Day. Most recently, he created PodChapters.com for quick transcribing & chaptering podcast episodes....

On episode #98 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 1/1/26 – 1/14/26. Host: Daniel Griffin Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Rhinovirus-Associated Lower Respiratory Tract Infection in Hospitalized Adult Patients: A Retrospective Cohort Study (JID) Demise of the Milwaukee Protocol for Rabies (CID) Reply to Willoughby on Demise of the Milwaukee Protocol for Rabies (CID) Bacterial Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods (CID) Reassessing the 2023 International Society for Cardiovascular Infectious Diseases Duke clinical criteria for infective endocarditis: Impact of excluding fever and updating diagnostic definition (CID) The diagnostic accuracy of procalcitonin for community-acquired bacteremia: an updated systematic review and meta-analysis (CMI: Clincal Microbiology and Infection) Noninferiority of One HPV Vaccine Dose to TwoDoses (NEJM) About the wastewater program (Colorado: Department of Public & Environment) Notes from the Field: Wastewater Surveillance for Measles Virus During a Measles Outbreak — Colorado, August 2025 (CDC: MMWR) Notes from the Field: Retrospective Analysis of Wild-Type Measles Virus in Wastewater During a Measles Outbreak — Oregon, March 24–September 22, 2024 (CDC:MMWR) Fungal The Last of US Season 2 (YouTube) Candidozyma auris (formerly Candida auris): Resistant, long-lasting, and everywhere (CMI: Clincal Microbiology and Infection) Long-range air dispersal as an important source of environmental contamination in Candida auris clustering: possible infection control implication (Infection Control & Hospital Epidemiology) Parasitic Dermlite Dermatoscopes (dermatoscopes.com) Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trials (BMJ) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients treated with ADT alone, ADT and an ARPI, ADT and docetaxel, and ADT, an ARPI, and docetaxel whose disease has progressed to mCRPC and the evidence that underpins these changes. Dr. Taplin highlights the updated algorithms within the guideline and the living format which will provide rapid, up-to-date, evidence-based information for clinicians and patients. Read the full living guideline update, "Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1." at www.asco.org/genitourinary-cancer-guidelines TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/genitourinary-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02693 Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I am interviewing Dr. Mary-Ellen Taplin from Dana-Farber Cancer Institute, lead author on "Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1." Thank you for being here today, Dr. Taplin. Dr. Mary-Ellen Taplin: Thank you, Brittany. It is a pleasure. Brittany Harvey: Before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Taplin who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. To dive into the content here and what we are here today to talk about, this living clinical practice guideline for systemic therapy for patients with metastatic castration-resistant prostate cancer is updated on an ongoing basis. Dr. Taplin, what prompted this latest update to the recommendations? Dr. Mary-Ellen Taplin: Thank you, Brittany. Several things prompted the latest update. There have been several phase III trials that have been practice-changing that have resulted in the last several years that needed to be added to the guidelines to inform clinicians of comprehensive treatment options. Brittany Harvey: Great, and it is great to have this updated guideline for readers. I would like to review the changes to the recommendations in this latest iteration across the patient populations that are outlined in the guideline. So, starting with: What are the updated recommendations for patients previously treated with androgen deprivation therapy alone whose disease has progressed to metastatic castration-resistant prostate cancer? Dr. Mary-Ellen Taplin: A nice feature of this guideline is that in addition to the tables, which provide detailed options, is at the end of the guidelines, our readers will find very clear algorithms that describe past treatment scenarios that patients could have had and then outline their treatment options. So it is very clear. Our clinicians will love these algorithms. And one of the changes for the disease state that you mentioned, which is the least treated castration-resistant state of prostate cancer which is previously treated with ADT alone, is that we recommend testing for mutations in the HRR, homologous recombination repair, genes. And the ones that are specifically known and applicable to prostate cancer are the BRCA genes. So there is clear recommendation of testing to remind us, as treating physicians, that now is the time, if it hasn't been done before, to institute both germline and somatic testing. And somatic testing, if it can be done on tissue, is preferable, but if not, the liquid biopsy approaches, the ctDNA approaches, have now advanced to the point that most patients with metastatic prostate cancer will be able to successfully have testing on the liquid biopsies. So that is number one, testing. And then the new treatment options include, if a patient does have an HRR gene alteration, and maybe about 20-25 percent of patients will be in that category, the combinations of an androgen pathway inhibitor and a PARP inhibitor are now treatment options. So for instance, talazoparib and enzalutamide; olaparib and abiraterone; or niraparib and abiraterone are some of the newer treatment options if the patient is HRR-positive. So, Brittany, in regard to patients treated with ADT alone, another new treatment option is the combination of radium-223 with enzalutamide. This is data based on the PEACE-3 trial which did show both an rPFS and OS benefit. For the patient who is HRR-negative and has previously not had an ARPI, just ADT alone, the combination of radium and enzalutamide is a new recommendation added to the algorithm. Brittany Harvey: Great. Thank you for reviewing those options for that patient population. And as you mentioned, I think those algorithms are very helpful as figures in the document. They are clear and can be used as at-a-glance tools for clinicians in their busy clinics. So then the next patient population that the guideline addresses: What is new for patients previously treated with androgen deprivation therapy and an androgen receptor pathway inhibitor whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Mary-Ellen Taplin: Right, so there are several new treatment options. So one is lutetium-PSMA-617, the trade name of which is Pluvicto. So that has now been FDA approved to use after progression on an AR pathway inhibitor and prior to the use of docetaxel chemotherapy. Brittany Harvey: Thank you for reviewing that new option for patients treated with androgen deprivation therapy and an ARPI whose disease has progressed. So then moving into the next set of recommendations, what does the panel now recommend for patients previously treated with androgen deprivation therapy and docetaxel whose disease has progressed to metastatic castration-resistant prostate cancer? Dr. Mary-Ellen Taplin: The next group of patients is those treated with ADT and docetaxel but haven't had an AR pathway inhibitor. Treatment options, again the HRR testing is important. So all patients with metastatic castration-resistant prostate cancer should be considered for both germline and somatic testing. I will repeat that. And if they are BRCA mutation positive, then the option of talazoparib and enzalutamide; olaparib and abiraterone; and niraparib and abiraterone.  So the AR pathway inhibitors plus the PARPs. There are three choices, so that can be somewhat complicated to think through, but most practitioners will get familiar with one of those combinations and be their go-to. So those are for BRCA-positive or HRR-positive. The talazoparib/enzalutamide trial also included non-BRCA HRR-positive gene mutations. And if they are HRR-negative, the option that we discussed above of radium and enzalutamide is new to the guideline. Brittany Harvey: Great. And then the last category of patients that is addressed in this update: What has changed for patients previously treated with androgen deprivation therapy, an androgen receptor pathway inhibitor, and docetaxel whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Mary-Ellen Taplin: Well, in this space, patients who are heavily pretreated with ADT and ARPI, one or even two, and chemotherapy, generally with docetaxel, the recommendations are not new within the last year or two. And they include Pluvicto; a PARP inhibitor if HRR-positive and they have not had one; second-line chemotherapy such as cabazitaxel. And if they are a very rare group and they have been sequenced and they are MSI-high, then considering a PD-1 inhibitor such as pembrolizumab can be considered. I will note that this is a very small percentage of mCRPC patients, probably in the order of 5 percent or less. Brittany Harvey: Understood. And I appreciate you reviewing the recommendations across all of these patient populations. It sounds like some of the key points is that HRR testing is very important for this patient population, and that the algorithms and the tables in the manuscript provide the full list of options that clinicians and patients can refer to. Dr. Mary-Ellen Taplin: Those are the highlights. And I will note in the tables, all the sections have "Special Considerations" sections because patients never fall into the black and white of one category. And those practical information or special situations sections of each of the recommendations can also help clinicians think about the individual patient in front of them and how they might choose one therapy over another since there are generally choices in all of these treatment situations. Brittany Harvey: Absolutely. That information for the individualized patient-clinician decision-making is really key when, as you said, there is a list of options to choose from. So in your view, what should clinicians know as they implement this living guideline update, and how do these changes impact patients? Dr. Mary-Ellen Taplin: I am so excited about this living document. ASCO has invested to developing the software to, in real time and iteratively, assess the new data that is published in prostate cancer and other diseases. So now we don't have to wait many years for the next guideline to come out. The guidelines will be updated every six months in prostate cancer based on this automatic search of the literature and a standing panel of both academic and community experts in prostate cancer treatment. So we no longer have to wait. That is what makes this guideline stand out to other guidelines. And in the digestible format that we have made, a clinician can seek out the table and read some details, seek out practical information for the recommendations, or they can just go right to the clear figure algorithm and take a quick snapshot. "Yep, I need to do HR testing. Done. Oh, okay. HR-positive or negative, these are my options," and then think about the individual patient in front of them when there is more than one option. For instance, a patient with cardiovascular history, abiraterone might not be a good choice for them. Or a patient with neuropathy, docetaxel might not be a good choice for them. But, within this guideline, it really will be up to date and focused on the busy clinician and knowing what the options are for their patient. Brittany Harvey: Definitely. This new era of living guidelines is very exciting and can provide even more up-to-date, evidence-based recommendations to really support clinicians and patients with metastatic castration-resistant prostate cancer. So in that vein, finally, what is the panel examining, and what are you excited for for new data coming out for future updates to this living guideline? Dr. Mary-Ellen Taplin: The future updates will depend on the results of phase III clinical trials. You know, there are many phase III trials ongoing in advanced prostate cancer, some of which include targeted therapy, which has been long awaited in prostate cancer. So such compounds as antibody-drug conjugates that are targeting certain proteins in prostate cancer cells, such as STEAP1, KLK2, B7-H3. So I think we are entering a new era in prostate cancer where we will be targeting cells and delivering drugs and applying them to prostate cancer if the trials are positive. So I think with AI and a large investment in prostate cancer clinical drug development, I think the treatment options for our patients will be rapidly evolving in a manner not previously seen. So the guidelines need to follow along with these developments. Brittany Harvey: Definitely. It sounds like an exciting time for research in metastatic castration-resistant prostate cancer. And we will await the result of those phase III trials to inform this guideline and lead to future updates. So I want to thank you so much for your work to rapidly and continuously update these guidelines and for your time today, Dr. Taplin. Dr. Mary-Ellen Taplin: Oh, it was my pleasure. ASCO has been a leader in this area, and as a practicing clinician, we are thankful for the investment and guidance that ASCO gives us. Brittany Harvey: Absolutely. And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/genitourinary-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines App, available in the  Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast, and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Welcome to the Civilian Medical Podcast episode 081       Opening: “You never know when you'll be the First Responder” Core framing Most cardiac arrest victims are not found by EMS. They are found by bystanders. “The first five minutes are up to the bystander, and that determines survival”     Why the Guidelines Changed Key point The American Heart Association didn't change CPR because civilians were doing it wrong— they changed it because stress breaks memory. 2020 vs 2025 framing 2020: Correct, but cognitively complex 2025: Correct and easier to recall under pressure “In emergencies, complexity kills time—and time kills.” When you learn CPR, you are not learning it to save a stranger; it's most likely to be a family member.       The Big Shift: One Model for Every Emergency Chain of Survival 2020 Different chains depending on age and setting 2025 One chain. Every person. Every place. “If you remember one thing: recognize → compress → shock.”     Choking: What changed 2020 Abdominal thrusts emphasized Back blows inconsistently taught for adults 2025 Adults & children: 5 back blows → 5 abdominal thrusts Infants: 5 back blows → 5 chest thrusts Why EMS cares Rhythm matters under stress. “Think of it like CPR for choking—structured, repeatable, automatic.”     Opioid Overdose 2020 Naloxone discussed, but not central 2025 Naloxone clearly included without replacing CPR Key teaching Naloxone does not restart a stopped heart. CPR and AED always come first. Soundbites “Naloxone wakes breathing—not circulation.” “Narcan doesn't buy you out of CPR.”       What EMS Hopes You'll Stop Overthinking CPR Quality Unchanged science Push hard Push fast Don't stop unless you must 2025 emphasis Start early > start perfect “You cannot make them more dead.”     Dispatcher CPR: The Invisible Teammate Why this matters Dispatchers now teach off the same simplified framework Civilians who know the 2025 model cooperate faster “The guidelines were written with the idea that the dispatcher is on speakerphone.”     What This Means for You (Practical Takeaways) Actionable conclusions You don't need to be a healthcare provider to do CPR You need the right equipment and the right training What training is Dietrich doing in his community? “Confidence saves more lives than certification.” “You don't rise to the occasion—you fall to your level of preparation.” Final line “If EMS could speak to every bystander before an emergency, this is what we'd say: You already know enough to save a life; do CPR.”     Medical Gear Outfitters Use Code CIVILIANMEDICAL for 10% off    Skinny Medic - @SkinnyMedic | @skinny_medic | Medical Gear Outfitters   Bobby - @rstantontx | @bobby_wales   

Welcome to the Civilian Medical Podcast episode 081       Opening: “You never know when you'll be the First Responder” Core framing Most cardiac arrest victims are not found by EMS. They are found by bystanders. “The first five minutes are up to the bystander, and that determines survival”     Why the Guidelines […]

What actually counts as a whole food — and why does that matter when it comes to sugar?In this episode, I unpack the difference between foods with added sugars and whole foods that naturally contain sugar, like fruit and dairy. I talk about what “minimally processed” really means, why "food products" that contain forms of added sugars have quietly become part of everyday eating...and how all of this affects cravings, blood sugar, and our general health.I also give my own opinion on the latest US nutrition guidelines that were published in January 2026. I'm not a nutrition expert, but in this episode I share what I've experienced over the last 10 years eating whole foods that don't contain added sugars.To get personalized guidance to stop emotional eating and break free from cravings, plus support and accountability... apply here to join the 90-day program, Freedom from Cravings Formula TODAY.Do the Cravings Quiz and take the first step to get rid of your cravings! Struggling with cravings? Download your 5 tips HERE to discover how you can get rid of cravings... even when you feel tired or stressed.To rate and review this podcast: scroll down in your podcast player on your phone and click on the stars. To leave a review, scroll down a little more and click on "Write a Review". Once you've finished, select “Send” or “Save” in the top-right corner. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed on your review. After selecting a nickname, tap OK. Your review may not be immediately visible, but it should be posted soon. Thank you! - NettaDisclaimer: Information provided by Life After Sugar is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. This is general information for educational purposes only. The information provided is not a substitute for medical or professional care. Life After Sugar is not liable or responsible for any advice, information, services or product you obtain through Life After Sugar. You should always seek...

The Other Human in the Room is on hiatus! For the next 3 months, you'll still be getting weekly episodes on your podcast feeds - but they'll all be re-releases of past favourites. I'm using this time to dream and explore new ideas and directions for the podcast. See you in March!Do you get stressed about following the guidelines? Or notice other colleagues seem stressed if anyone strays off the guidelines? Commute to work with Joan as she explores the idea of guidelines legalism and how we can trust our clinical brains in the midst of guideline confusion. Learn more about Hippocratic Collective: https://hippocraticcollective.org/Connect on Instagram: https://www.instagram.com/joanchanmd

Ryan Gable hosts Ground Zero (January 12, 2026)*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.WEBSITEFREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVE-X / TWITTERFACEBOOKINSTAGRAMYOUTUBERUMBLE-BUY ME A COFFEECashApp: $rdgable PAYPAL: rdgable1991@gmail.comRyan's Books: https://thesecretteachings.info - EMAIL: rdgable@yahoo.com / rdgable1991@gmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

Send us a textDo you struggle with your "quiet time" in terms of trying keep it fresh and interactive with our Lord? You're not alone! This great message by Mr. Elmo Joseph offers great advice on how to rejuvenate your "appointment with God," or quiet time.Click here to download the free handout "The Quiet Time: Ten Motivations and Guidelines to Consider" 

In this season 8 premiere of Talking Sleep, host Dr. Seema Khosla welcomes three members of the AASM guideline committee—Dr. Rami Khayat, Professor and Division Chief of Pulmonary, Allergy & Critical Care Medicine and Director of Penn State Health Sleep Services; Dr. Shirine Allam, Professor of Medicine at Emory University and Program Director for the Pulmonary and Critical Care Fellowship at the Atlanta VA Medical Center; and Dr. Christine Won, Medical Director of Yale Centers for Sleep Medicine and Professor of Medicine at Yale University—to discuss the newly released AASM clinical practice guidelines for central sleep apnea treatment. The conversation begins with the rigorous process behind guideline development, clarifying the distinction between evidence-based recommendations and expert opinion. The panel systematically walks through each recommendation, addressing CPAP use across various CSA etiologies including primary CSA, heart failure-related CSA, medication-induced CSA, treatment-emergent CSA, and CSA due to medical conditions. A surprising recommendation against BPAP without backup rate generates discussion about why backup rates matter and why heart failure patients are excluded from certain BPAP recommendations. The experts tackle the controversial topic of adaptive servo-ventilation (ASV), explaining why it's now conditionally recommended even for heart failure patients despite SERVE-HF trial concerns. They clarify that newer ASV algorithms differ from devices used in that study and emphasize the importance of patient-provider shared decision-making and treatment at experienced centers. Practical implementation guidance covers oxygen therapy for heart failure and high-altitude CSA, including insurance coverage challenges. The panel discusses acetazolamide use across multiple CSA etiologies, providing concrete advice on prescribing and follow-up protocols. Transvenous phrenic nerve stimulation receives attention as an option for select patients, with candid discussion about its invasive nature, accessibility limitations, and high costs. The episode addresses the shift toward viewing CSA treatment as chronic disease management, including billing code G211 implications. The experts emphasize that guidelines guide but don't constrain clinical judgment, stressing the importance of monitoring beyond AHI—including patient symptoms and quality of life improvements. Whether you're treating complex central sleep apnea, navigating insurance coverage, or seeking clarity on when ASV is appropriate, this review provides essential guidance for implementing evidence-based CSA treatment. Join us for this season premiere that translates complex guidelines into practical clinical applications.

Welcome to Episode 52 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! NSAIDs National Institutes of Health. (2022). Nonsteroidal antiinflammatory drugs. LiverTox: Clinical and research information on drug-induced liver injury. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK548614/ LFTs / Drug-Induced Liver Injury American Association for the Study of Liver Diseases. (2023). Practice guidance on drug, herbal, and dietary supplement–induced liver injury. Hepatology. Retrieved from https://journals.lww.com/hep/fulltext/2023/03000/aasldpracticeguidanceondrug,herbal,and.28.aspx Toxicology Screening StatPearls Publishing. (2023). Toxicology screening. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK499901/ Academy of Diagnostic & Laboratory Medicine. (2023). Testing for drugs of misuse to support the emergency department. Retrieved from https://myadlm.org/science-and-research/academy-guidance/testing-for-drugs-of-misuse-to-support-the-emergency-department CT Utilization / Imaging American College of Emergency Physicians. (2022). The renewed necessity of robust clinical judgment in CT scan utilization. ACEP Now. Retrieved from https://www.acepnow.com/article/the-renewed-necessity-of-robust-clinical-judgment-in-ct-scan-utilization/ Appropriate Testing / Overuse Context Melnick, E. R., et al. (2023). GRACE-2: Guidelines for reasonable and appropriate care in the emergency department. Academic Emergency Medicine. Retrieved from https://onlinelibrary.wiley.com/doi/10.1111/acem.14495 More from us: Our CME courses: EM Boot Camp: https://courses.ccme.org/course/embootcamp/about EM Boot Camp Pharmacology Workshop: https://bit.ly/2I44xld Bouncebacks! Medical & Legal: https://courses.ccme.org/education/bouncebacks-medical-and-legal Mastering Emergency Imaging: https://courses.ccme.org/education/mastering-emergency-imaging Advanced EM Boot Camp: https://courses.ccme.org/course/advancedbootcamp/about Advanced ECG Workshop: https://bit.ly/aembc-ecg Advanced Imaging Workshop: https://bit.ly/aembc-imaging EM & Acute Care: https://courses.ccme.org/course/ema/about National EM Board Review: https://courses.ccme.org/course/nembr/about High Risk Emergency Medicine: https://courses.ccme.org/course/hrem The Heart Course: https://courses.ccme.org/course/theheartcourse The Cadaver-Based Procedures & Suturing Courses: https://courses.ccme.org/course/cadaver EM:Prep LLSA Review: https://courses.ccme.org/course/em-prep/about EMCert Module Mastery: https://courses.ccme.org/course/emcertmodule USC Trauma Course: https://courses.ccme.org/course/usc-trauma ACOEP Scientific Assembly: https://courses.ccme.org/course/acoep Mastering Acute Care Charting - 2023 Updates: https://courses.ccme.org/course/macc Flourishing in Medicine: https://courses.ccme.org/course/flourishing-in-medicine The DEA Licensee SUD Training Course: https://courses.ccme.org/course/dea ACOFP On-Demand: https://courses.ccme.org/education/acofp25-clinical-selects The Airway and Lung Course: https://courses.ccme.org/education/airway Mastering Pediatric Emergencies: https://courses.ccme.org/course/pediatric-em Innovations in ED Management: https://courses.ccme.org/course/innovationsined American Osteopathic Association Courses: https://aoa.coursehost.net EM Cases Summit: https://courses.ccme.org/education/em-cases-summit-2024 IncrEMentuM Conference – On-Demand: https://courses.ccme.org/education/incrementum-2025 Our social media: TikTok: https://www.tiktok.com/@ccmecourses Instagram: https://www.instagram.com/ccmecourses Facebook: https://www.facebook.com/CenterForMedicalEducation LinkedIn: https://www.linkedin.com/in/rickbukata Our podcasts: The 2 View Podcast (Free): Subscribe on Apple Podcasts https://apple.co/3rhVNZw​ Subscribe on Google Podcasts: http://bit.ly/2MrAHcD​ Subscribe On Spotify: http://spoti.fi/3tDM4im Risk Management Monthly Podcast (Paid CME): https://www.ccme.org/riskmgmt ** The information in this video is not intended nor implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained in this video is for general information purposes only and does not replace a consultation with your own doctor/health professional. The information in this video is for informational purposes only and not for the purpose of providing legal advice. You should contact your attorney to obtain advice with respect to any particular issue or problem. Nothing here should be construed to form an attorney-client relationship. ** emergencymedicine #cme

Food allergies, specifically peanut allergies have been increasing in children. But key research changed policy and the past 10 years have seen a steady decline. In a rare win for the goodies, we see how science shaped public policy and made things better for a whole generation of children.  Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: Chris article on peanut and food allergies: https://montrealgazette.com/opinion/columnists/labos-food-allergies-a-hard-nut-to-crack-but-theres-some-good-news The old recommendations: https://publications.aap.org/pediatrics/article-abstract/106/2/346/62820/Hypoallergenic-Infant-Formulas?redirectedFrom=fulltext The new recommendations: https://www.cps.ca/en/documents/position/allergenic-solids#ref2 Increasing food allergies: http://www.jacionline.org/article/S0091-6749(10)00575-0/abstract The LEAP study: https://www.nejm.org/doi/full/10.1056/NEJMoa1414850 The effect the LEAP study had on allergy rates in children” https://publications.aap.org/pediatrics/article/156/5/e2024070516/204636/Guidelines-for-Early-Food-Introduction-and?autologincheck=redirected Skin contact as a risk factor for peanut allergies: https://www.nejm.org/doi/full/10.1056/NEJMoa013536 Oral Immunotherapy for peanut allergies: https://www.nejm.org/doi/full/10.1056/NEJMoa1812856 Met-analysis of immunotherapy for peanut allergies: https://pubmed.ncbi.nlm.nih.gov/31030987/

In this Bell Work Talk, Nancy Blaney and Claire Coughlin of the Animal Welfare Institute will discuss the relationship between child abuse and animal abuse, which frequently occur in the same homes. Given the special role that pets play in providing both emotional and social support to children, witnessing or being forced to participate in animal abuse is especially traumatic. Asking questions about pets and pet abuse can provide practitioners with unique insights into violent household dynamics and inform their intervention efforts. Claire Coughlin: Claire Coughlin (she/her) has a master's degree in human development and family studies and extensive experience in both social services and animal advocacy. For over a decade, she specialized in evidence-based education and support services for children and families impacted by abuse and neglect. She now serves as the director of the Companion Animals Program for the Animal Welfare Institute (AWI) and oversees AWI's work on the link between animal maltreatment and human violence, including the Safe Havens for Pets program which supports domestic violence survivors with pets. Nancy Blaney has advocated on behalf of animals for more than 40 years and is currently Director of Government Affairs at the Animal Welfare Institute. She works with federal and state legislators and regulators, the law enforcement community, veterinarians, and other stakeholder groups to improve animal welfare, the prosecution of animal cruelty crimes, and public awareness of the relationship between animal abuse and other forms of violence, particularly all forms of family violence. Nancy serves on a variety of advisory bodies and has co-authored several articles and chapters. Resources: Guidelines for Asking Children About Pets and Pet Abuse: https://awionline.org/sites/default/files/uploads/documents/AWI-Asking-Children-About-Pets.pdf Guidelines for Asking Children About Pets and Pet Abuse(Spanish): https://awionline.org/sites/default/files/uploads/documents/AWI-Asking-Children-About-Pets-Spanish.pdf When Children Witness Animal Abuse (An Assessment Guide): https://awionline.org/sites/default/files/uploads/documents/AWI-When-Children-Witness-Animal-Abuse.pdf When Children Witness Animal Abuse (An Assessment Guide in Spanish): https://awionline.org/sites/default/files/uploads/documents/AWI-When-Children-Witness-Animal-Abuse-Spanish.pdf Animal Cruelty Issues: What Juvenile and Family Court Judges Need to Know https://www.ncjfcj.org/wp-content/uploads/2025/12/NCJFCJ_ALDF_Animal-Cruelty-TAB_Final.pdf Survey: We'd really like to learn more about what you think of the podcast, and what you'd like to hear in future episodes. https://forms.gle/dos4a11PEmCgth7Z8

About this episode: Citing updated research on the health risks of drinking alcohol, Canada changed consumption guidelines in 2023, making global headlines for its steep drop in what's viewed as "low risk" drinking. In this episode: One of the architects of those guidelines explains how these recommendations were developed, their efficacy as a public health intervention, and what to make of the U.S.'s new guidelines. Guests: Tim Stockwell, PhD, is a scientist at the Canadian Institute for Substance Use Research and emeritus professor of psychology at the University of Victoria. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: US has new alcohol guidelines: How much is healthy to drink?—The Hill Is That Drink Worth It to You?—New York Times Canada's Guidance on Alcohol and Health—Canadian Centre on Substance Use and Addiction What's behind Canada's drastic new alcohol guidance—BBC Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Health Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brooke Rollins, along with other colleagues, introduced their new food guidelines to the nation. Their message: eat real food! We discuss some of the big changes, how food and our spiritual life are connected, and look at a concerning study on 16 out of 24 kinds of baby formulas contain heavy metals. Important information!

Recorded: November 16, 2025

AUA Guidelines: Salvage Therapy for Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Yaw Nyame, MD, MS, MBA Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol. 2024;211(4):509-517. https://www.auajournals.org/doi/10.1097/JU.0000000000003892 Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol. 2024;211(4):518-525. https://www.auajournals.org/doi/10.1097/JU.0000000000003891 Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part III: salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol. 2024;211(4):526-532. https://www.auajournals.org/doi/10.1097/JU.0000000000003890

The new USDA food guide was recently released and there's been a lot of buzz around the new guidelines.Sandra and Rob compare Canada's food guide with the new USDA food guide for Americans and discuss some important elements of each country's food guide features. Episodes mentioned include:Ep.23. Fats, Grease and Oil, Lubricate the Body and Skin From Withinhttps://youtu.be/otQdbY-s_vo?si=2OmnoQZkaksVD7KnEp. 172. Do Dietary Fats Affect Inflammation? Take the Quiz!https://youtu.be/OOSLRwNBPG8?si=2ywKMRAVE7m91klHEp.14. The MIND Diet - Nutrition and Brain Healthhttps://youtu.be/anY72wscg_A?si=tZSu-D2iyP4y2E_-Nutrition Nuggets 86. Mind Diet Quizhttps://youtu.be/2BDVTL6MdtY?si=43essBG87HnIunHBEp. 170. Grains and Inflammation - Friend or Foehttps://youtu.be/OYPL4mKVkTk?si=knmw13OQKDqO5jXTSalt, Sugar, Fat. How the Food Giants Hooked Us. Michael Mosshttps://www.npr.org/sections/thesalt/2013/02/26/172969363/how-the-food-industry-manipulates-taste-buds-with-salt-sugar-fatEnjoying the show? Consider leaving a 5 star review (if you loved it!), and/or sharing this episode with your friends and family :)Don't forget to visit our social media pages as well. You can find us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Your support helps fuel the stoke and keeps the show going strong every week. Thanks!Website: mywifethedietitian.comEmail: mywifetherd@gmail.com

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh continues the Combinating with ICH series by breaking down how the International Council for Harmonisation (ICH) guidelines are organized and why that structure matters for drug and drug-device combination products.Subhi walks through the four main ICH guideline families, Quality (Q), Safety (S), Efficacy (E), and Multidisciplinary (M), and explains how each fits into the broader product lifecycle. The episode places particular emphasis on the Quality guidelines, which form the backbone of pharmaceutical development, manufacturing control strategies, and lifecycle management.Rather than a deep dive into requirements, this episode is designed to orient listeners to the full ICH landscape. It helps teams understand where different guidelines apply, who typically owns them, and how they collectively shape regulatory expectations. Future episodes in the series will explore individual Quality guidelines in detail.In this episode, you will learnWhat an ICH guideline is and how it differs from regulations and standardsWhy guidelines still matter during inspections and enforcementHow ICH organizes its guidance into Q, S, E, and M categoriesA high-level overview of the Quality Guidelines (Q1 through Q14), including:Stability (Q1)Analytical validation and development (Q2 and Q14)Impurities (Q3)Quality by Design and risk management (Q8 and Q9)Pharmaceutical Quality Systems and lifecycle management (Q10 through Q12)Continuous manufacturing (Q13)How different functional teams interact with different parts of the ICH frameworkThe next episode begins the deep dive into the Quality Guidelines, starting with ICH Q1 on Stability.Timestamps00:00 Introduction to the Series00:48 Overview of ICH Guidelines01:36 What an ICH Guideline Is and Is Not03:04 The Four ICH Guideline Categories04:08 Quality Guidelines Overview08:46 Safety Guidelines Overview09:28 Efficacy Guidelines Overview10:33 Multidisciplinary Guidelines Overview11:28 Wrap-Up and Next StepsSubhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

In this episode of SurgOnc Today, we discuss the recently updated ASCO guidelines for axillary staging with sentinel lymph node biopsy in breast cancer, as well as considerations for their application in a multidisciplinary setting. This episode is moderated by Dr. Ashley Woodfin from the University of Wisconsin, who is joined by Dr. Clara Park from Brigham and Women's Hospital and Dr. Andrea Abbott from Medical University of South Carolina for a in-depth discussion regarding the guidelines implementation and important considerations.

This week, Dr. Kahn breaks down the newly released USDA 2025–2030 Dietary Guidelines and the surprising upside-down food pyramid they present. He explains how the final report differs from last year's Advisory Committee recommendations, including changes in committee membership and the influence of advisors with financial ties to the meat and dairy industries. Looking back at the original 1980 dietary guidelines, Dr. Kahn asks an important question: how much has really changed? His takeaway remains refreshingly simple—eat food, mostly plants, not too much. Short topics this week include urinary measurements of protein intake, optimal timing for surgery in dilated aortic roots, the cardiovascular risk of lipoprotein(a), and whether the science behind the Blue Zones truly holds up. You can order a bottle of olive oil for just $1 at getfreshDRKAHN.com. To join the next group ProLon fast, order your kit as soon as possible at prolonlife.com/DRKAHN. If you want it a touch shorter or more punchy for Apple Podcasts specifically, I can trim it another 10–15%.

In this Complex Care Journal Club podcast episode, Drs. Reshma Amin and Christopher Baker discuss a clinical practice guideline from the American Thoracic Society on the care of infants and children with tracheostomies. They describe the role of interprofessional and family-centered decision-making, safety- and ethics-driven recommendations, and next steps for implementation across diverse healthcare settings. SPEAKERS Reshma Amin, MD, MSc Staff Respirologist, Director of Sleep Medicine and Long-term Ventilation The Hospital for Sick Children Senior Associate Scientist, SickKids Research Institute Professor, The University of Toronto Christopher D. Baker, MD Director, Ventilation Care Program, Children's Hospital Colorado Professor of Pediatrics - Pulmonary Medicine University of Colorado School of Medicine HOST Kilby Mann, MD Associate ‌Professor Pediatric Rehabilitation Medicine Children's Hospital Colorado DATE Initial publication date: January 13, 2026. JOURNAL CLUB ARTICLE Amin R, Agarwal A, Chiang J, Collaco JM, Cristea AI, Propst EJ, Sobotka SA, Balakrishnan K, Benscoter D, Brenner MJ, Castro-Codesal ML, Cuevas Guaman M, Daines CL, Dawson JA, Edwards JD, Graham RJ, Henningfeld JK, Hoekstra NE, Jackson AJ, Johnson RF, Kam K, Kun SS, Napolitano N, Pacheco A, Panitch HB, Prager JD, Shi JY, Soma M, St-Laurent A, Syed F, Watters KF, Zielinski D, Ho ATN, Velagapudi RK, Zeba F, Knight SL, Iyer N, Baker CD. Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Nov;211(11):2001-2020. doi: 10.1164/rccm.202508-2055ST. PMID: 41123183; PMCID: PMC12618984. OTHER ARTICLES REFERENCED Sherman JM, Davis S, Albamonte-Petrick S, Chatburn RL, Fitton C, Green C, Johnston J, Lyrene RK, Myer C 3rd, Othersen HB, Wood R, Zach M, Zander J, Zinman R. Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000 Jan;161(1):297-308. doi: 10.1164/ajrccm.161.1.ats1-00. PMID: 10619835. ‌ Sterni LM, Collaco JM, Baker CD, Carroll JL, Sharma GD, Brozek JL, Finder JD, Ackerman VL, Arens R, Boroughs DS, Carter J, Daigle KL, Dougherty J, Gozal D, Kevill K, Kravitz RM, Kriseman T, MacLusky I, Rivera-Spoljaric K, Tori AJ, Ferkol T, Halbower AC; ATS Pediatric Chronic Home Ventilation Workgroup. An Official American Thoracic Society Clinical Practice Guideline: Pediatric Chronic Home Invasive Ventilation. Am J Respir Crit Care Med. 2016 Apr 15;193(8):e16-35. doi: 10.1164/rccm.201602-0276ST. PMID: 27082538; PMCID: PMC5439679. ‌ TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/wkhzg7pznk5cgb23sk9xg7w7/Amin_and_Baker_Final_transcript_1-9-26_kh_ra_Baker Clinicians across healthcare professions, advocates, researchers, and patients/families are all encouraged to engage and provide feedback! You can recommend an article for discussion using this form: https://forms.gle/Bdxb86Sw5qq1uFhW6. Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Amin R, Baker CD, Mann K. Balancing Safety, Practicality, and Equity in Pediatric Tracheostomy Guidelines. 1/2026. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/balancing-safety-practicality-and-equity-in-pediatric-tracheostomy-guidelines.

The Trump administration released new dietary guidelines this month that call for Americans to eat whole foods and limit highly processed products.The US Secretary of Health and Human Services Robert F. Kennedy Jr has issued the guidelines which “evangelise real food,” such as protein and “end the war on healthy fats.”Guidelines include images of an inverted pyramid that places meats and vegetables at the widest point on top, reversing the classic depiction of the American food pyramid.Freelance Journalist with The Times UK Harry Wallop tried out the diet for five days, and joins Seán to give his take.Image: Reuters

In this episode of the Optimal Body Podcast, hosts and Doctors of Physical Therapy Doc Jen and Dr. Dom welcome Dr. Margie Davenport, an exercise physiologist and leading expert on pregnancy and postpartum physical activity. Together, they discuss the latest research and Canadian guidelines on safe pregnancy exercise, debunk common myths, and highlight the benefits of movement for physical and mental health during and after pregnancy. The conversation covers pelvic floor training, sleep, breastfeeding, and practical tips for returning to pregnancy exercise, empowering listeners with evidence-based recommendations and resources for every stage of the perinatal journey. Whether you're new to pregnancy exercise or looking to refine your routine, this episode provides valuable insights for a healthy and active pregnancy.Needed Discount:Jen trusted Needed Supplements for fertility, pregnancy, and beyond! Support men and women's health with vitamins, Omega-3, and more. Used by 6,000+ pros. Use code OPTIMAL for 20% off at checkout!Free Week of the Jen Health Membership:Get a free week of Jen Health Membership! Access 12 plans crafted by Doc Jen, PT. We'll match you with the best plan for your goals. Check it out today and use code OPTIMAL for a discount on your first month!Dr. Davenport's Resources:Dr Margie's WebsiteDr Margie on IGDr Margie on YoutubeWe think you'll love:Free Week of Jen HealthJen's InstagramDom's InstagramYouTube ChannelWhat You'll Learn from Dr. Margie:03:03 Dr. Davenport explains her role, the development of guidelines, and the goal to dispel myths about exercise during and after pregnancy.06:41 Discussion of global consensus: 150 minutes of moderate-vigorous activity during pregnancy, and 120 minutes postpartum, including aerobic, resistance, and pelvic floor training.09:55 Guidelines on sleep: no set duration, but physical activity improves sleep quality and mental health for new parents.13:07 Pelvic floor training goes...For full show notes and resources visit https://jen/health/podcast/443 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What's really being served in the new American food guidelines—and how does it affect your health, weight, and peace of mind? In today's episode, we break down the latest American food guidelines and translate the headlines into real-life wisdom. We'll talk about what's helpful, what's missing, and how to approach these guidelines without losing your own common sense.   This is The Dish: what's on the plate, what's behind the messaging, and what actually nourishes your body. In This Episode, We Discuss: What the new American food guidelines are really emphasizing How ultra-processed foods quietly made their way into "normal" eating The problem with one-size-fits-all nutrition advice Why knowing your own health goals matters when approaching the research True health isn't built by rigid rules—it's built through awareness, wisdom, and consistency.  If you've ever felt confused, pressured, or overwhelmed by nutrition advice—this episode is for you. Ready for more guidance and support? Head to www.emilyvinzantmd.com  or follow Dr. Emily on Facebook and Instagram for more science-backed common sense when it comes to your eating and your health.

The government announced a new health schedule for childhood vaccines, and then released new guidelines for the American diet that added a heavy emphasis on meat and fats. Here's the latest.

The government announced a new health schedule for childhood vaccines, and then released new guidelines for the American diet that added a heavy emphasis on meat and fats. Here's the latest.

The government announced a new health schedule for childhood vaccines, and then released new guidelines for the American diet that added a heavy emphasis on meat and fats. Here's the latest.

The CDC announced Monday a major overhaul of the U.S. childhood vaccine schedule, reducing the number of routine immunizations recommended for children. In December, President Trump directed Health and Human Services officials to examine how other developed nations schedule vaccines and to reconsider the U.S. approach. FDA Commissioner Dr. Marty Makary said the changes are intended to restore public trust in health institutions that was lost during the pandemic. However, criticism has been fierce. Lawmakers on both sides of the aisle have pushed back, and the American Academy of Pediatrics has called the move dangerous and unnecessary. Vaccine schedules are handled by the states, meaning states may continue to mandate certain vaccines for school attendance. The updated recommendations also do not eliminate insurance coverage for any vaccines. The CDC changes create three categories. The eleven vaccines that remain in the recommended category include measles, mumps, rubella, polio, pertussis, HPV, and chickenpox. A second category recommends vaccines for individuals considered high-risk, including hepatitis A and B and RSV. The third category includes vaccines available by personal choice after consultation with a doctor, including COVID-19, flu, rotavirus, and others. Earlier this week, former CDC Director Dr. Robert Redfield joined FOX News Rundown host Jessica Rosenthal to discuss the new and reduced childhood vaccine schedule recommendations. Dr. Redfield, author of the new book Redfield's Warning: What I Learned (But Couldn't Tell You) Might Save Your Life, explained why he supports the changes, while also emphasizing the importance of doctors clearly explaining the benefits of vaccines. He also discussed why public trust has eroded and why encouraging vaccine choice and transparency could ultimately lead more Americans to get the shots needed to protect themselves from disease. We often have to cut interviews short during the week, but we thought you might like to hear the full conversation. Today on Fox News Rundown Extra, we share our entire interview with former CDC Director Dr. Robert Redfield—and more of his perspective on vaccines. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, we explore the newly published INTEGRATE guidelines—the first truly international algorithm for schizophrenia treatment. Should clozapine be started after just 12 weeks? When are long-acting injectables appropriate for first-episode patients? Discover how these guidelines aim to standardize quality care worldwide. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CME: Quick Take Vol. 77 INTEGRATE: New Schizophrenia Treatment Guidelines

Hearing God's voice is something Jesus tells us is possible for all of his sheep. But if we go into it with the wrong ideas about it, it can cause us to miss the voice of God and become frustrated and quit listening for it. In this message Pastor Joel walks through some guidelines (five of them, to be exact) to consider what will put us in a position to hear the voice of God well in our day to day lives. They have to do with the centrality of grace and God speaking, how God sorts out our hearts when he speaks, why we should be looking for God to speak to us in quieter ways rather than with bright, neon lights, and more.

As seen on Gutfeld! Its the end of the week and Greg brings out the leftovers! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Date: January 5, 2026 Reference: Robblee et al. 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache 2025 Dec Happy New Year, SGEMers! What better way to start 2026 than with an SGEM Xtra about migraine headaches? We were originally […] The post SGEM Xtra: Hit Me with Your Best Block – 2025 AHS ED Migraine Guidelines first appeared on The Skeptics Guide to Emergency Medicine.

Jordan Sather and Nate Prince open this episode of MAHA News with personal MAHA wins and losses before moving into a packed week of health policy developments. The discussion centers on the CDC's sweeping reduction of the childhood vaccine schedule, including the removal of dozens of doses, the return of shared clinical decision-making, and calls for placebo-controlled randomized trials. The hosts react to statements from RFK Jr., HHS officials, and media coverage framing the changes as historic, while unpacking questions around liability, state responses, and long-term implications. The episode also dives into the newly released dietary guidelines and the inverted food pyramid, emphasizing real food, reduced ultra-processed consumption, and how these changes will affect school lunches, SNAP, and military meals. Additional segments touch on pesticide manufacturer immunity, Supreme Court considerations, gut health, sugar addiction, and practical lifestyle shifts, with live chat engagement woven throughout as the show closes.

Today, we're talking about an ICE agent fatally shooting a Minneapolis woman; the USDA's new food pyramid; the Trump administration's threefold plan for Venezuela; and other top news for Friday, January 9th. Stay informed while remaining focused on Christ with The Pour Over. Looking to support us? You can choose to pay ⁠⁠⁠⁠here⁠⁠⁠⁠ Check out our sponsors! We actually use and enjoy every single one. Cru Wild Alaskan Safe House Project Gloo QAVA CCCU Filament Bible Upside Mosh LMNT Theology in the Raw Not Just Sunday Podcast Bible Gateway Plus

Skip to the start of the episode: 11:52 In today's Friday solo recap on the Optimal Protein Podcast, I break down the most important takeaways from my recent conversation with Dr. Gabrielle Lyon — and why this episode has major implications for fat loss, metabolic health, and women's body composition.

Kenan Thompson stops by to catch up, discuss his new children's book Unfunny Bunny, and reflect on his record-setting run on ‘Saturday Night Live.' Also, NBC News medical contributor Dr. Natalie Azar breaks down what the new U.S. dietary guidelines mean, including a redesigned food pyramid. Plus, our Shop TODAY team shares a batch of products and gadgets to help reset routines for the new year. And, Martha Stewart whips up a few of her favorite winter citrus recipes and cocktails. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Studies suggest that once you stop taking wegovy, you could gain the weight you lost back. Open AI is launching Chat GPT Health. New US dietary guidelines change the alcohol guidelines.See omnystudio.com/listener for privacy information.